| scholarly article | Q13442814 |
| P2093 | author name string | Sang Woo Park | |
| Jong Sun Rew | |||
| Sung Bum Cho | |||
| Sung Kyu Choi | |||
| Hyunsoo Kim | |||
| Yeon Joo Kim | |||
| Hyoung Ju Hong | |||
| Du Hyeon Lee | |||
| Eun Ae Cho | |||
| P2860 | cites work | Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation | Q61895904 |
| Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis | Q74645276 | ||
| NIH Consensus Statement on Management of Hepatitis C: 2002 | Q75442808 | ||
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
| Diagnosis, management, and treatment of hepatitis C | Q29620656 | ||
| Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C | Q33378124 | ||
| Lymphatic transport of proteins after subcutaneous administration | Q33856578 | ||
| Natural history of hepatitis C: its impact on clinical management | Q33873345 | ||
| Obesity predisposes to increased drainage following axillary node clearance: a prospective audit | Q34344017 | ||
| Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C. | Q34365442 | ||
| Management issues in chronic viral hepatitis: hepatitis C. | Q34619371 | ||
| Prevalence of Hepatitis C Virus Antibody Among Korean Adults | Q34650873 | ||
| Side effects of therapy for chronic hepatitis C. | Q35133495 | ||
| Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial | Q35142681 | ||
| High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. | Q35206324 | ||
| Impact of obesity on treatment of chronic hepatitis C. | Q36490255 | ||
| Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C | Q38501611 | ||
| Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. | Q40078224 | ||
| Peginterferon alfa-2a in patients with chronic hepatitis C. | Q43001243 | ||
| Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity | Q43031928 | ||
| Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection | Q43047952 | ||
| Peginterferon alfa-2a plus ribavirin for initial treatment of chronic hepatitis C in Korea | Q45076673 | ||
| Impact of asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C. | Q46866205 | ||
| Relationships between the Body Mass Index and body composition. | Q51012341 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 21-26 | |
| P577 | publication date | 2012-04-26 | |
| P1433 | published in | Chonnam Medical Journal | Q26842647 |
| P1476 | title | Body mass index and nonresponse to antiviral treatment in korean patients with genotype 2 and 3 chronic hepatitis C. | |
| P478 | volume | 48 |
| Q42202021 | Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis | cites work | P2860 |
Search more.